Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn2r1 Inhibitors

The "vomeronasal 2, receptor 1" (V2R1) is part of a complex and specialized chemosensory system that is essential for detecting pheromones, the chemical signals crucial for inter-individual communication in many animals. V2R1 is a member of the vomeronasal type 2 receptor family, which is expressed in the vomeronasal organ (VNO), an olfactory structure located at the base of the nasal cavity.V2R1 receptors are G protein-coupled receptors (GPCRs) that bind to specific ligands, leading to intracellular signaling cascades that ultimately result in neuronal responses. These receptors are characterized by a seven-transmembrane domain structure, typical of GPCRs, which allows them to interact with a variety of ligand molecules. Upon binding to their respective pheromone ligands, V2R1 receptors undergo a conformational change that activates the associated G proteins, which then trigger downstream signaling pathways.

The activation of V2R1 and related receptors in the VNO leads to the initiation of signal transduction mechanisms that convey information to the accessory olfactory bulb (AOB) in the brain. This neural processing is fundamental for behaviors influenced by pheromones, such as mating, territoriality, and aggression, which are vital for species survival and reproduction.V2R1 receptors have a significant role in the discrimination of individual pheromones, contributing to the vast repertoire of detectable chemical cues. The specificity of V2R1 to its ligands is of particular interest, as it underlines the complexity of chemical communication and the evolution of species-specific signaling mechanisms. Research on V2R1 continues to unravel the intricacies of pheromone detection and the molecular basis of social and reproductive behaviors in animals.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Cyclopamine inhibits the Hedgehog signaling pathway, which may indirectly impact the expression of VN2R1 as it can modulate downstream signaling events.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Pertussis toxin inhibits G-protein coupled receptor signaling via ADP-ribosylation, potentially affecting VN2R1, a G-protein coupled receptor, and its expression.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$94.00
$186.00
71
(2)

H89 is a protein kinase A (PKA) inhibitor, potentially impacting cAMP-mediated signaling pathways, which can influence the expression of G-protein coupled receptors.

YM 254890

568580-02-9sc-507356
1 mg
$510.00
(0)

YM-254890 is a specific Gq protein inhibitor, potentially affecting G-protein coupled receptor signaling, including potential impact on VN2R1 expression.

Fumagillin

23110-15-8sc-200377
sc-200377A
sc-200377B
sc-200377C
sc-200377D
1 mg
5 mg
25 mg
100 mg
500 mg
$104.00
$393.00
$541.00
$1363.00
$5212.00
1
(1)

NF023 is a P2X receptor antagonist, which may impact purinergic signaling pathways, potentially influencing the expression of G-protein coupled receptors, including VN2R1.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a selective Rho-associated protein kinase (ROCK) inhibitor, potentially impacting downstream signaling pathways that may influence G-protein coupled receptor expression, including VN2R1.

Latrunculin B

76343-94-7sc-203318
1 mg
$240.00
29
(1)

Latrunculin A disrupts actin polymerization, potentially impacting cellular processes involved in the expression and localization of G-protein coupled receptors, including VN2R1.